ABVC BIOPHARMA, INC. (ABVC)
SEC filings, insider trading & institutional ownership from EDGAR.
Institutions
15
$105.62M held
Latest filings
10-K, 10-Q, 8-K, Form 4 & 13D/G. Sourced directly from SEC EDGAR
No filings are available yet.
Top holders
13F & 13D/G · latest quarter
| Holder | Filed | Value |
|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | May 14, 2026 | $92.26M |
| Dimensional Fund Advisors LP | May 7, 2026 | $11.86M |
| Vanguard Capital Management | Aug 13, 2026 | $591.7K |
| GEODE CAPITAL MANAGEMENT, LLC | Aug 12, 2026 | $360.4K |
| CITADEL ADVISORS LLC | Sep 1, 2026 | $132.2K |
ABVC's filings are public. The insight is one click away.
Scrutar's AI reads every ABVC filing and surfaces what matters. Red flags, risk shifts, disclosure quality and key relationships. Cited to the source, free with an account.
Red Flag Detection20+ forensic checks per filingRisk RadarYear-over-year changes in risk factorsFiling DNADisclosure quality scored across six dimensionsSupply Chain GraphCustomers, suppliers & competitors mapped
Analyze ABVC filingsNo credit cardAI reports included on the free plan
Never miss a ABVC filing.
Get an email when ABVC files its next 8-K, Form 4, 10-K or 10-Q with the SEC. Free, no account needed.
Free foreverNo account requiredOne-click unsubscribe
Data as of Sep 16, 2026Source: SEC EDGAR.